Cencora (NYSE:COR) (NYSE: COR) is a leading global pharmaceutical distribution and services company, offering a comprehensive range of supply chain solutions to healthcare providers, biotechnology firms, and pharmaceutical manufacturers. The company specializes in the procurement, storage, and delivery of branded and generic pharmaceuticals, over-the-counter healthcare products, and specialty medications. Through a network of distribution centers and technology-driven logistics systems, Cencora ensures continuity of supply for a broad spectrum of therapeutic categories, supporting hospitals, pharmacies, and long-term care facilities worldwide.
In addition to its core distribution business, Cencora provides a suite of value-added services designed to enhance patient access and optimize medication management. These services include specialty pharmacy operations, medication adherence programs, patient support services, and regulatory compliance consulting. Cencora’s strategic partnerships with drug developers and biotech companies facilitate the launch of novel therapies, while its data analytics capabilities enable real-time visibility across the supply chain, helping clients navigate complex market dynamics and regulatory environments.
Originally formed in 2001 through the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation, the company operated for many years under the AmerisourceBergen name. In October 2023, it rebranded as Cencora to reflect its broadened mission of connecting healthcare to people around the globe. Headquartered in Warrendale, Pennsylvania, Cencora maintains operations across North America, Europe, Asia Pacific, and select emerging markets, operating hundreds of distribution centers that adhere to stringent quality and safety standards.
Under the leadership of Chairman and Chief Executive Officer Steven H. Collis, Cencora continues to pursue strategic growth through acquisitions, technological innovation, and expanded service offerings. The company’s executive team emphasizes sustainability initiatives, digital transformation, and workforce development as key pillars for future growth. With a focus on strengthening global healthcare infrastructure and improving patient outcomes, Cencora remains a pivotal partner for stakeholders throughout the pharmaceutical value chain.
